BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28984474)

  • 1. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
    Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
    Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
    Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
    Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
    Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
    Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
    Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of 14-3-3ΞΆ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway.
    Shen J; Zhou Y; Zhang X; Peng W; Peng C; Zhou Q; Li C; Wen T; Shi Y
    Aging (Albany NY); 2019 Nov; 11(21):9280-9294. PubMed ID: 31689237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells.
    Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J
    Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
    Jin J; Ryu HS; Lee KB; Jang JJ
    PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
    Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
    Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma.
    Du J; Lan T; Liao H; Feng X; Chen X; Liao W; Hou G; Xu L; Feng Q; Xie K; Liao M; Chen X; Huang J; Yuan K; Zeng Y
    Mol Cancer; 2022 Jan; 21(1):18. PubMed ID: 35039066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.
    Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP
    Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.